Antibody Response in Healthcare Workers During the SARS-CoV-2 Gamma Variant Outbreak in Manaus, Brazil
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf318 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Charlene Siza und 20 weiteren Autor:innen. Beteiligte Einrichtung: COVID-19 Response - International Task Force, Centers for Diseases Control and Prevention (CDC), Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Health Personnel, COVID-19, SARS-CoV-2, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aimed to evaluate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific binding and neutralizing antibody responses in healthcare workers (HCWs) who received coronavirus disease 2019 (COVID-19) vaccines, with or without postvaccination infections.
Methods
We conducted a prospective, observational cohort study of HCW in 2 hospitals in Manaus, Brazil. From 31 March through 31 May 2021, HCWs had nasal swabs collected and questionnaires administered weekly for 4 visits. Nasal swabs were tested for SARS-CoV-2 by real-time reverse transcription polymerase chain reaction (rRT-PCR). Blood specimens were obtained at visits 1 and 4 unless the HCW was found to be infected. If infected, a blood specimen was collected on days 14 and 28 after symptom onset or date of positive specimen, if asymptomatic. COVID-19 vaccination cards, state immunization records, and self-reported history of previous SARS-CoV-2 infection were obtained. Fully vaccinated HCWs who tested SARS-CoV-2 rRT-PCR positive were classified as postvaccination infections.
Results
A total of 771 HCWs were enrolled, with 73.7% (568/771) fully vaccinated. Anti–SARS-CoV-2 S1 immunoglobulin G and neutralizing antibody levels showed steep decay within the first 50 days after COVID-19 vaccination. HCWs with prior SARS-CoV-2 infection had slower visible decay after 50 days compared with those without prior infection. We identified 12 postvaccination infections of 16 HCWs who were SARS-CoV-2 rRT-PCR+, including 4 who also reported previous infection. Those positive for SARS-CoV-2 had lower baseline neutralizing antibody levels against Gamma and Delta variants preinfection (median log10 titers [interquartile range]: Gamma, 1.5 [3]; Delta: 0 [0.25]) compared to those who remained rRT-PCR negative (median log10 titers [interquartile range]: Gamma, 3 [2]; Delta, 1 [2]).
Conclusions
Our findings highlight the importance of routine antibody surveillance, targeted boosters, and hybrid immunity in low and middle income countries. Timely booster doses for HCWs and the development of new vaccines against emerging variants can help sustain immunity and prevent workforce shortages, strengthening healthcare resilience in resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- COVID-19 Response - International Task Force, Centers for Diseases Control and Prevention (CDC), Atlanta, Georgia, USA.
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Fundação de Vigilância em Saúde do Estado do Amazonas, Manaus, Amazonas, Brazil.
- Universidade de São Paulo, Escola de Enfermagem, São Paulo, Sao Paulo, Brazil.
- Laboratório Central do Amazonas (LACEN), Manaus, Amazonas, Brazil.
- Hospital Pronto Socorro 28 de Agosto, Manaus, Amazonas, Brazil.
ORCID-Profile: Charlene Siza, Mateusz Plucinski, Maria Clara Padoveze, Lucia Y I Nichiata, Luciana Silva-Flannery, Kassia Lima, Juliette Morgan, Cristiano Fernandes da Costa, Felipe G Naveca, Pritesh Lalwani
Zitieren
APA
Siza, C., Plucinski, M., Lessa, F. C., Campelo, E., Padoveze, M. C., Vieira, A. R., Parra, G., Araujo, G., Nichiata, L. Y. I., Silva-Flannery, L., Lima, K., Tapajos, A. C., Vieira, A., Morgan, J., Freire Esteves, R. J., Marston, B., Fernandes da Costa, C., Naveca, F. G., Amorim Ramos, T. C., …, & Brazil Healthcare Personnel COVID-19 team (2025). Antibody Response in Healthcare Workers During the SARS-CoV-2 Gamma Variant Outbreak in Manaus, Brazil. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf318
Vancouver
Siza C, Plucinski M, Lessa FC, Campelo E, Padoveze MC, Vieira AR, et al. Antibody Response in Healthcare Workers During the SARS-CoV-2 Gamma Variant Outbreak in Manaus, Brazil. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf318
BibTeX
@article{Siza2025,
author = {Siza, Charlene and Plucinski, Mateusz and Lessa, Fernanda C and Campelo, Evelyn and Padoveze, Maria Clara and Vieira, Antonio R and Parra, Gemma and Araujo, Guilherme and Nichiata, Lucia Y I and Silva-Flannery, Luciana and Lima, Kassia and Tapajos, Aida Cristina and Vieira, Ariana and Morgan, Juliette and Freire Esteves, Roberto J and Marston, Barbara and Fernandes da Costa, Cristiano and Naveca, Felipe G and Amorim Ramos, Tatyana C and Lalwani, Pritesh and Brazil Healthcare Personnel COVID-19 team, Brazil Healthcare Personnel COVID-19 team},
title = {Antibody Response in Healthcare Workers During the SARS-CoV-2 Gamma Variant Outbreak in Manaus, Brazil},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf318}
}
EUVIMED